Through its Community & Media Gathering – Lunch with Experts: Ngerti Prostat Edition, Mayapada Hospital Kuningan highlights the importance of early detection and advances in minimally invasive treatment for benign prostatic hyperplasia (BPH).
Mayapada Hospital Kuningan (MHKN) hosted its Community & Media Gathering – Lunch with Experts: Ngerti Prostat Edition on Monday, 16th of November 2026, at Seribu Rasa Restaurant in Menteng, Central Jakarta. The event brought together medical experts, media representatives, Key Opinion Leaders (KOLs) and community members to raise public awareness of prostate health, particularly benign prostatic hyperplasia (BPH), its symptoms, risk factors and impact on men’s quality of life.
The discussion featured dr. Johannes Aritonang, B.MedSc., Sp.U, DU, FICS, a Urology Specialist, and dr. Vivi Lesmana, Sp.PD-KR, an Internal Medicine Specialist. They shared insights into recognising the signs of BPH, understanding its potential complications and exploring available treatment options, including Water Vapor Therapy (Rezūm™), a minimally invasive procedure that does not require major surgery. The therapy is available at the Tahir Uro-Nephrology Center, one of Mayapada Hospital Kuningan’s centres of excellence for comprehensive kidney and urinary tract care, covering early detection, diagnosis, treatment and recovery.
Through this initiative, MHKN aims to encourage greater public understanding of prostate health and the latest medical technologies for managing BPH. By involving media partners, KOLs and community representatives, the hospital hopes to help more people recognise potential symptoms, understand available treatment options and seek appropriate medical attention at an early stage.
The Importance of Prostate Health as Men Age
As men grow older, their risk of developing various health conditions increases, including benign prostatic hyperplasia (BPH). This condition affects approximately 70% of men over the age of 60 and 90% of those over 80. However, BPH often goes unnoticed, as only around 50% of patients experience noticeable urinary symptoms.
The high prevalence of BPH, combined with the fact that some patients experience few or no apparent symptoms, highlights the importance of prostate health education, awareness of risk factors and regular medical examinations to support early detection and appropriate treatment.
BPH is a non-cancerous enlargement of the prostate gland, which is located below the bladder and produces seminal fluid. As the prostate enlarges, it can press against the urethra, restricting urine flow and making it difficult to empty the bladder completely.
Several factors are associated with an increased risk of BPH, including ageing, changes in testosterone levels and lifestyle or health-related conditions. These include physical inactivity, a low-fibre diet, obesity, metabolic syndrome, chronic inflammation of the prostate and cardiovascular disease.
Common BPH symptoms are classified as Lower Urinary Tract Symptoms (LUTS) and may include a weak or interrupted urine stream, difficulty emptying the bladder, increased urinary frequency, particularly at night, sudden urges to urinate, post-urination dribbling and urinary retention, in which a person is unable to urinate at all.
When left unaddressed, these symptoms can interfere with daily activities and significantly affect a man’s quality of life. Medical evaluation is therefore essential to establish an accurate diagnosis and determine the most appropriate treatment based on each patient’s condition.
Water Vapor Therapy (Rezūm™) at Mayapada Hospital Kuningan
One of the treatment options available for BPH at Mayapada Hospital Kuningan is Water Vapor Therapy (Rezūm™), a minimally invasive procedure designed to reduce prostate enlargement without the need for major surgery or external incisions.
The procedure takes approximately 10–15 minutes and involves delivering sterile water vapour directly into the enlarged prostate tissue that is compressing the urethra. The heat from the vapour causes the targeted tissue to shrink, after which it is gradually absorbed by the body, helping to restore smoother urine flow.
The therapy is designed to preserve ejaculatory function, while improvements in urinary symptoms typically occur gradually over several weeks following treatment.
At MHKN, Water Vapor Therapy (Rezūm™) is performed using a specialised, sterile, single-use Rezūm Delivery Device. This helps minimise the risk of cross-infection while maintaining precision in delivering the water vapour to the targeted prostate tissue.
The treatment is available through the Tahir Uro-Nephrology Center, which provides specialised care for kidney and urinary tract conditions, from early detection and diagnosis to treatment and recovery.
Tahir Uro-Nephrology Center at Mayapada Hospital Kuningan
The Tahir Uro-Nephrology Center at Mayapada Hospital Kuningan provides comprehensive diagnostic and treatment services for kidney and urinary tract conditions in both adult and paediatric patients.
Its services range from early detection and diagnostic examinations to non-invasive and minimally invasive procedures for various conditions, including kidney stones, benign prostatic hyperplasia (BPH), urinary tract infections, acute and chronic kidney disease and kidney failure, as well as kidney complications associated with hypertension and diabetes.
These services are supported by a multidisciplinary medical team, alongside diagnostic facilities and advanced medical technologies, to ensure that treatment is tailored to each patient’s individual condition and needs.
Integrated Urology Expertise Across the Mayapada Hospital Network
The urology services at Mayapada Hospital Kuningan are further supported by the integration of medical expertise and technology across the wider Mayapada Hospital network.
One example is the da Vinci Xi robotic surgical system, available at Mayapada Hospital Jakarta Selatan (MHJS). The technology supports robotic-assisted procedures for prostate cancer, including radical prostatectomy, as well as kidney cyst surgery.
This integration expands the range of urological technologies and procedures available across Mayapada Hospital, enabling patients to access treatment options suited to their individual medical needs.
Through continued medical innovation, multidisciplinary collaboration and public education initiatives, Mayapada Hospital Kuningan remains committed to strengthening prostate and urinary tract care, encouraging early detection and helping patients make informed decisions about their health.



